A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Avanafil Impurity 56 | Avanafil Impurity 56. Uses: For analytical and research use. CAS No. 1830294-64-8. Molecular formula: C23H24ClN7O4. Mole weight: 497.94. Catalog: APB1830294648. |  |
| Avanafil Impurity 6 | Avanafil Impurity 6. Uses: For analytical and research use. Alternative Names: ethyl 4-((2-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate. Molecular formula: C16H18ClN3O3S. Mole weight: 367.85. Catalog: APB02655. | |
| Avanafil Impurity 6 | Avanafil Impurity 6. Uses: For analytical and research use. CAS No. 2520113-98-6. Molecular formula: C24H24ClN7O4. Mole weight: 509.95. Catalog: APB2520113986. | |
| Avanafil Impurity 63 | Avanafil Impurity 63. Uses: For analytical and research use. CAS No. 59566-45-9. Molecular formula: C6H5N3. Mole weight: 119.13. Catalog: APB59566459. | |
| Avanafil Impurity 68 | Avanafil Impurity 68. Uses: For analytical and research use. CAS No. 41965-95-1. Molecular formula: C8H11Cl2NO. Mole weight: 208.08. Catalog: APB41965951. | |
| Avanafil Impurity 69 | Avanafil Impurity 69. Uses: For analytical and research use. CAS No. 5909-24-0. Molecular formula: C8H9ClN2O2S. Mole weight: 232.68. Catalog: APB5909240. | |
| Avanafil Impurity 7 | Avanafil Impurity 7. Uses: For analytical and research use. Alternative Names: 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylic acid. Molecular formula: C14H14ClN3O3S. Mole weight: 339.8. Catalog: APB02656. | |
| Avanafil Impurity 7 | Avanafil Impurity 7. Uses: For analytical and research use. CAS No. 1638497-26-3. Molecular formula: C23H26ClN7O3. Mole weight: 483.96. Catalog: APB1638497263. | |
| Avanafil Impurity 75 | Avanafil Impurity 75. Uses: For analytical and research use. Molecular formula: C26H38ClN7O4. Mole weight: 548.09. Catalog: APB06513. | |
| Avanafil Impurity 76 | Avanafil Impurity 76. Uses: For analytical and research use. Molecular formula: C23H26ClN7O4. Mole weight: 499.96. Catalog: APB06514. | |
| Avanafil Impurity 77 | Avanafil Impurity 77. Uses: For analytical and research use. Molecular formula: C23H26ClN7O4. Mole weight: 499.96. Catalog: APB06515. | |
| Avanafil Impurity 78 | Avanafil Impurity 78. Uses: For analytical and research use. Molecular formula: C41H45Cl2N11O6. Mole weight: 858.78. Catalog: APB06517. | |
| Avanafil Impurity 79 | Avanafil Impurity 79. Uses: For analytical and research use. Molecular formula: C26H38ClN7O4. Mole weight: 548.09. Catalog: APB06516. | |
| Avanafil Impurity 8 | Avanafil Impurity 8. Uses: For analytical and research use. CAS No. 2221018-00-2. Molecular formula: C30H30Cl2N6O7. Mole weight: 657.51. Catalog: APB2221018002. | |
| Avanafil Impurity 8 | Avanafil Impurity 8. Uses: For analytical and research use. Alternative Names: (S)-4-((3-chloro-4-hydroxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide. CAS No. 330785-05-2. Molecular formula: C22H24ClN7O3. Mole weight: 469.92. Catalog: APB330785052. | |
| Avanafil Impurity 80 | Avanafil Impurity 80. Uses: For analytical and research use. CAS No. 2259648-80-9. Molecular formula: C32H30FN5O4. Mole weight: 567.62. Catalog: APB2259648809. | |
| Avanafil Impurity 81 | Avanafil Impurity 81. Uses: For analytical and research use. Molecular formula: C23H27N7O4. Mole weight: 465.51. Catalog: APB06518. | |
| Avanafil Impurity 82 | Avanafil Impurity 82. Uses: For analytical and research use. CAS No. 372115-53-2. Molecular formula: C24H29N7O4. Mole weight: 479.54. Catalog: APB372115532. | |
| Avanafil Impurity 83 | Avanafil Impurity 83. Uses: For analytical and research use. CAS No. 372117-76-5. Molecular formula: C16H18ClN3O5S. Mole weight: 399.85. Catalog: APB372117765. | |
| Avanafil Impurity 9 | Avanafil Impurity 9. Uses: For analytical and research use. Alternative Names: ((S)-1-(4-((3-chloro-4-methoxybenzyl)amino)-5-((pyrimidin-2-ylmethyl)carbamoyl)pyrimidin-2-yl)pyrrolidin-2-yl)methyl 4-((3-chloro-4-methoxybenzyl)amino)-2-((S)-2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate. Molecular formula: C41H45Cl2N11O6. Mole weight: 858.77. Catalog: APB02653. | |
| Avanafil Impurity 9 | Avanafil Impurity 9. Uses: For analytical and research use. CAS No. 2520114-34-3. Molecular formula: C23H26ClN7O3. Mole weight: 483.96. Catalog: APB2520114343. | |
| Avanafil Impurity O | Avanafil Impurity O. Uses: For analytical and research use. CAS No. 330785-83-6. Molecular formula: C20H25ClN4O4. Mole weight: 420.89. Catalog: APB330785836. | |
| Avanafil Impurity P | Avanafil Impurity P. Uses: For analytical and research use. CAS No. 330785-81-4. Molecular formula: C16H18ClN3O3S. Mole weight: 367.85. Catalog: APB330785814. | |
| Avanafil Impurity R-1 | Avanafil Impurity R-1. Uses: For analytical and research use. CAS No. 1638497-22-9. Molecular formula: C20H25ClN4O4. Mole weight: 420.89. Catalog: APB1638497229. | |
| Avanafil Impurity R-2 | Avanafil Impurity R-2. Uses: For analytical and research use. CAS No. 1638497-25-2. Molecular formula: C18H21ClN4O4. Mole weight: 392.84. Catalog: APB1638497252. | |
| Avanafil Impurity V | Avanafil Impurity V. Uses: For analytical and research use. CAS No. 330785-99-4. Molecular formula: C15H16ClN3O4. Mole weight: 337.76. Catalog: APB330785994. | |
| Avanafil metabolite M4 | Avanafil metabolite M4 is a major active metabolite of the phosphodiesterase 5 (PDE5) inhibitor avanafil. Avanafil is metabolized by the cytochrome P450 (CYP450) isoforms CYP3A4 and CYP2C to the major metabolites avanafil metabolite M4 and avanafil metabolite M16, as well as minor metabolites. Avanafil metabolite M4 inhibits PDE5 with 18% of the potency of avanafil. Grade: ≥98%. Molecular formula: C23H26ClN7O4. Mole weight: 499.95. |  |
| Avanafil Related Compound 1 | Avanafil Related Compound 1 is a pivotal entity within the biomedical research, primarily employed in the synthesand exploration of Avanafil, a pharmaceutical intervention targeting erectile dysfunction. Synonyms: 4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-MethylsulfinylpyriMidine; Ethyl 4-((3-chloro-4-Methoxybenzyl)aMino)-2-(Methylsulfinyl)pyriMidine-5-carboxylate. Grade: > 95%. CAS No. 330785-82-5. Molecular formula: C16H18ClN3O4S. Mole weight: 383.86. | |
| Avanafil Related Compound 1 | Avanafil Related Compound 1. Uses: For analytical and research use. CAS No. 330785-82-5. Molecular formula: C16H18ClN3O4S. Mole weight: 383.85. Catalog: APB330785825. | |
| Avanafil Related Compound 2 | Avanafil Related Compound 2. Uses: For analytical and research use. CAS No. 1364671-62-4. Molecular formula: C19H19ClN6O2S. Mole weight: 430.91. Catalog: APB1364671624. | |
| Avanbulin | Avanbulin (BAL27862) is a potent, Colchicine site-binding, tubulin assembly inhibitor. Avanbulin inhibits tubulin assembly at 37 °C with an IC50 of 1.4 μM. Avanbulin binds to tubulin with an apparent Kd value of 244 nM. Avanbulin can be used for the research of cancer and cell division[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAL27862. CAS No. 798577-91-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-106008. |  |
| Avapritinib | BLU-285 is a potent and selective inhibitor of exon 17 mutant KIT (IC50 = 0.27 nM for KIT D816V). BLU-285 showed dose-dependent, robust anti-tumor efficacy in a TKI-resistant KIT exon 11/17 mutant GIST PDX model through inhibition of tumor growth, proliferation, KIT signaling and induction of apoptosis. Synonyms: (1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine; BLU-285; BLU 285; BLU285; UNII-513P80B4YJ; SCHEMBL16652297. CAS No. 1703793-34-3. Molecular formula: C26H27FN10. Mole weight: 498.56. | |
| Avapritinib | Avapritinib (BLU-285) is a selective, highly potent, and orally active inhibitor of KIT and PDGFRA activation loop mutant kinases, targeting KIT D816V (IC50:0.27 nM) and PDGFRA D842V (IC50:0.24 nM), and attenuates the transport functions of ABCB1 and ABCG2. It binds to the active conformation of the kinases and exhibits antitumor activity. Category: Active pharmaceutical ingredients. CAS No. 1703793-34-3. Product ID: API1703793343. Molecular formula: C26H27FN10. Mole weight: 498.56. |  |
| Avapritinib | Avapritinib (BLU-285) is a highly potent, selective, and orally active KIT and PDGFRA activation loop mutant kinases inhibitor with IC50s of 0.27 and 0.24 nM for KIT D816V and PDGFRA D842V, respectively. Avapritinib (BLU-285) binds the active conformation of the kinase and shows antitumor activity. Avapritinib (BLU-285) attenuates the transport function of both ABCB1 and ABCG2[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BLU-285. CAS No. 1703793-34-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-101561. | |
| Avarofloxacin | Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial agent being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia with oral activity. Avarofloxacin (JNJ-Q2) is an aminoethylidenylpiperidine fluoroquinolone that demonstrates antibacterial effect against numerous Gram-positive bacteria with a mean 0.12 mg/L MIC90 value. Avarofloxacin (JNJ-Q2) has potential for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: JNJ-Q2. CAS No. 878592-87-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-16764. | |
| Avarofloxacin | Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial drug under development for treating acute bacterial skin and skin structure infections, as well as community-acquired pneumonia. Category: Active pharmaceutical ingredients. CAS No. 878592-87-1. Product ID: API878592871. Molecular formula: C21H23F2N3O4. Mole weight: 419.42. | |
| Avarofloxacin hydrochloride | Avarofloxacin hydrochloride is an antibacterial drug agent. Uses: Avarofloxacin hydrochloride is an antibacterial drug agent. Synonyms: Avarofloxacin HCl; JNJ-Q2 hydrochloride; 7-[(3E)-3-(2-amino-1-fluoroethylidene)piperidin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid hydrochloride; JNJ-32729463 hydrochloride; JNJ 32729463 hydrochloride. Grade: >98 %. CAS No. 1001162-01-1. Molecular formula: C21H24ClF2N3O4. Mole weight: 455.89. | |
| Avarol | Antibacterial against selected Gram-positive strains, antifungal. Anticancer compound. Antileukemic. Antimitotic agent. Antiviral compound. Inhibits HIV activity. Anti-inflammatory. Synovial phospholipase A2, cyclooxygenase and lipoxygenase inhibitor. Modulator of superoxide dismutase and glutathione peroxidase. Platelet aggregation inhibitor. Anti-psoriatic, mediated by inhibition of TNF-alpha generation and NF-kappaB activation. Group: Biochemicals. Alternative Names: NSC 306951. Grades: Highly Purified. CAS No. 55303-98-5. Pack Sizes: 1mg. Molecular Formula: C21H30O2. US Biological Life Sciences. |  Worldwide |
| Avasimibe | Avasimibe (CI-1011; PD-148515) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT; also called SOAT)) inhibitor with IC50s of 24 and 9.2 μM for ACAT1 and ACAT2, respectively[1]. Avasimibe can be used for the research of prostate cancer[2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CI-1011; PD-148515. CAS No. 166518-60-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13215. | |
| Avasimibe | Avasimibe inhibits Lipoprotein(a) accumulation in the culture media of primary monkey hepatocyte in a dose-dependent manner with 11.9% -31.3% inhibition, the change is mainly associated with decreased ApoA. Uses: Cytochrome p-450 cyp3a inducers. Synonyms: CI-1011; CI 1011; CI1011; ((2,4,6-Tris(1-methylethyl)phenyl)acetyl)sulfamic acid 2,6-bis(1-methylethyl)phenyl este; Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl esterr. Grade: >98%. CAS No. 166518-60-1. Molecular formula: C29H43NO4S. Mole weight: 501.72. | |
| Avasimibe | Avasimibe. Group: Biochemicals. Alternative Names: CI 1011; PD 148515; N-[2-[2, 4, 6-tris (1-methylethyl) phenyl]acetyl]-2-sulfamic Acid 6-Bis(1-methylethyl)phenyl Ester. Grades: Highly Purified. CAS No. 166518-60-1. Pack Sizes: 25mg. Molecular Formula: C29H43NO4S, Molecular Weight: 501.72. US Biological Life Sciences. | Worldwide |
| Avasopasem manganese | Avasopasem manganese (GC4419; M-40419) is a potent superoxide dismutase mimetic that rapidly and specifically converts O2*- to hydrogen peroxide (H2O2), arresting the initiation of this cascade. Avasopasem manganese can be used for the research of severe oral mucositis (SOM) and cancer[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: GC-4419; M-40419. CAS No. 435327-40-5. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109110. | |
| Avatrombopag | Avatrombopag (AKR-501) is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag mimics the biological activities of TPO. Avatrombopag increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AKR-501; E5501; YM477. CAS No. 570406-98-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-13463. | |
| Avatrombopag | Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 is an orally-active TPO receptor agonist that may be useful in the treatment of patients with thrombocytopenia. Synonyms: AKR-501; AKR 501; AKR501; YM477; YM-477; YM 477; E5501; AS 1670542; AS1670542; AS-1670542. Grade: 98%. CAS No. 570406-98-3. Molecular formula: C29H34Cl2N6O3S2. Mole weight: 649.65. | |
| Avatrombopag (AKR-501) | Avatrombopag (AKR-501). Uses: For analytical and research use. Alternative Names: 1-(3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid. CAS No. 570406-98-3. Molecular formula: C29H34Cl2N6O3S2. Mole weight: 648.15. Catalog: APB570406983. | |
| Avatrombopag hydrochloride | Avatrombopag (AKR-501) hydrochloride is an orally active, nonpeptide thrombopoietin (TPO) receptor agonist (EC50=3.3 nM). Avatrombopag hydrochloride mimics the biological activities of TPO. Avatrombopag hydrochloride increases platelet production by activating the intracellular signaling system, and promotes production of platelets and megakaryocytes from hemopoietic precursor cells. Avatrombopag hydrochloride is a substrate of cytochrome P450 (CYP) 2C9 and CYP3A[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AKR-501 hydrochloride; E5501 hydrochloride; YM477 hydrochloride. CAS No. 570403-17-7. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-13463B. | |
| Avatrombopag hydrochloride | Avatrombopag hydrochloride is a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. Synonyms: Avatrombopag (hydrochloride). Grade: 98%. CAS No. 570403-17-7. Molecular formula: C29H35Cl3N6O3S2. Mole weight: 686.12. | |
| Avatrombopag Impurity 1 | Avatrombopag Impurity 1. Uses: For analytical and research use. Alternative Names: 5-chloro-6-(4-(ethoxycarbonyl)piperidin-1-yl)nicotinic acid. CAS No. 931395-73-2. Molecular formula: C14H17ClN2O4. Mole weight: 312.75. Catalog: APB931395732. | |
| Avatrombopag Impurity 10 | Avatrombopag Impurity 10. Uses: For analytical and research use. Alternative Names: (4-cyclohexylpiperazin-1-yl)(5,6-dichloropyridin-3-yl)methanone. Molecular formula: C16H21Cl2N3O. Mole weight: 342.26. Catalog: APB01192. | |
| Avatrombopag Impurity 100 | Avatrombopag Impurity 100. Uses: For analytical and research use. Alternative Names: 5-chloro-6-(2-(ethoxycarbonyl)piperidin-1-yl)nicotinic acid. Molecular formula: C14H17ClN2O4. Mole weight: 312.75. Catalog: APB03307. | |
| Avatrombopag Impurity 101 | Avatrombopag Impurity 101. Uses: For analytical and research use. Alternative Names: ethyl 1-(3-chloro-5-(4-(ethoxycarbonyl)piperidine-1-carbonyl)pyridin-2-yl)piperidine-4-carboxylate. Molecular formula: C22H30ClN3O5. Mole weight: 451.94. Catalog: APB03306. | |
| Avatrombopag Impurity 102 | Avatrombopag Impurity 102. Uses: For analytical and research use. Alternative Names: 1,3-bis(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)guanidine. Molecular formula: C35H45Cl2N9S4. Mole weight: 790.96. Catalog: APB03305. | |
| Avatrombopag Impurity 103 | Avatrombopag Impurity 103. Uses: For analytical and research use. Alternative Names: ethyl 5,6-dichloronicotinate. CAS No. 401566-69-6. Molecular formula: C8H7Cl2NO2. Mole weight: 220.05. Catalog: APB401566696. | |
| Avatrombopag Impurity 104 | Avatrombopag Impurity 104. Uses: For analytical and research use. Alternative Names: 5-chloro-4-(4-chlorothiophen-2-yl)thiazol-2-amine. Molecular formula: C7H4Cl2N2S2. Mole weight: 251.16. Catalog: APB03304. | |
| Avatrombopag Impurity 105 | Avatrombopag Impurity 105. Uses: For analytical and research use. Alternative Names: 5-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid. CAS No. 677762-31-1. Molecular formula: C7H6ClNO3. Mole weight: 187.58. Catalog: APB677762311. | |
| Avatrombopag Impurity 108 | Avatrombopag Impurity 108. Uses: For analytical and research use. Alternative Names: 4,4'-bis(4-chlorothiophen-2-yl)-[5,5'-bithiazole]-2,2'-diamine. Molecular formula: C14H8Cl2N4S4. Mole weight: 431.41. Catalog: APB03303. | |
| Avatrombopag Impurity 11 | Avatrombopag Impurity 11. Uses: For analytical and research use. Alternative Names: 5-bromo-4-(5-bromo-4-chlorothiophen-2-yl)thiazol-2-amine. CAS No. 2401867-89-6. Molecular formula: C7H3Br2ClN2S2. Mole weight: 374.50. Catalog: APB2401867896. | |
| Avatrombopag Impurity 12 | Avatrombopag Impurity 12. Uses: For analytical and research use. Alternative Names: 5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-hydroxynicotinamide. CAS No. 762237-66-1. Molecular formula: C23H25Cl2N5O2S2. Mole weight: 538.51. Catalog: APB762237661. | |
| Avatrombopag Impurity 12 (Hydrochloride) | Avatrombopag Impurity 12 (Hydrochloride). Uses: For analytical and research use. Alternative Names: 5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-hydroxynicotinamide hydrochloride. CAS No. 570403-05-3. Molecular formula: C23H25Cl2N5O2S2·HCl. Mole weight: 574.96. Catalog: APB570403053. | |
| Avatrombopag Impurity 13 | Avatrombopag Impurity 13. Uses: For analytical and research use. Alternative Names: 4-(4-chlorothiophen-2-yl)-N5-(4-(4-chlorothiophen-2-yl)thiazol-2-yl)thiazole-2,5-diamine. Molecular formula: C14H8Cl2N4S4. Mole weight: 431.41. Catalog: APB01815. | |
| Avatrombopag Impurity 14 | Avatrombopag Impurity 14. Uses: For analytical and research use. Alternative Names: N5-(5-bromo-4-(4-chlorothiophen-2-yl)thiazol-2-yl)-4-(4-chlorothiophen-2-yl)thiazole-2,5-diamine. Molecular formula: C14H7BrCl2N4S4. Mole weight: 510.3. Catalog: APB01816. | |
| Avatrombopag Impurity 15 | Avatrombopag Impurity 15. Uses: For analytical and research use. Alternative Names: 5,6-dichloronicotinoyl chloride. CAS No. 54127-29-6. Molecular formula: C6H2Cl3NO. Mole weight: 210.45. Catalog: APB54127296. | |
| Avatrombopag Impurity 16 | Avatrombopag Impurity 16. Uses: For analytical and research use. Alternative Names: ethyl 1-(2-amino-4-(4-chlorothiophen-2-yl)thiazol-5-yl)piperidine-4-carboxylate. Molecular formula: C15H18ClN3O2S2. Mole weight: 371.91. Catalog: APB01191. | |
| Avatrombopag Impurity 17 | Avatrombopag Impurity 17. Uses: For analytical and research use. Alternative Names: 5-chloro-6-hydroxynicotinic acid. CAS No. 54127-63-8. Molecular formula: C6H4ClNO3. Mole weight: 173.55. Catalog: APB54127638. | |
| Avatrombopag Impurity 18 | Avatrombopag Impurity 18. Uses: For analytical and research use. Alternative Names: 5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide. CAS No. 2626934-45-8. Molecular formula: C25H30Cl2N6OS2. Mole weight: 565.58. Catalog: APB2626934458. | |
| Avatrombopag Impurity 18 (Trifluoroacetate) | Avatrombopag Impurity 18 (Trifluoroacetate). Uses: For analytical and research use. Alternative Names: 5-chloro-N-(4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)-6-(dimethylamino)nicotinamide 2,2,2-trifluoroacetate. Molecular formula: C25H30Cl2N6OS2·CF3COOH. Mole weight: 679.6. Catalog: APB02918. | |
| Avatrombopag Impurity 19 | Avatrombopag Impurity 19. Uses: For analytical and research use. Alternative Names: 5-(4-cyclohexylpiperazin-1-yl)-4-(4,5-dichlorothiophen-2-yl)thiazol-2-amine. CAS No. 570407-63-5. Molecular formula: C17H22Cl2N4S2. Mole weight: 417.42. Catalog: APB570407635. | |
| Avatrombopag Impurity 2 | Avatrombopag Impurity 2. Uses: For analytical and research use. Alternative Names: 6-(4-carboxypiperidin-1-yl)-5-chloronicotinic acid. CAS No. 958457-83-5. Molecular formula: C12H13ClN2O4. Mole weight: 284.70. Catalog: APB958457835. | |
| Avatrombopag Impurity 20 | Avatrombopag Impurity 20. Uses: For analytical and research use. Alternative Names: 1-(3-chloro-5-((5-(4-cyclohexylpiperazin-1-yl)-4-(4,5-dichlorothiophen-2-yl)thiazol-2-yl)carbamoyl)pyridin-2-yl)piperidine-4-carboxylic acid. Molecular formula: C29H33Cl3N6O3S2. Mole weight: 684.10. Catalog: APB01190. | |
| Avatrombopag Impurity 21 | Avatrombopag Impurity 21. Uses: For analytical and research use. Alternative Names: 2-(4-carboxypiperidin-1-yl)-3-chloro-5-((4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl)carbamoyl)pyridine 1-oxide. Molecular formula: C29H34Cl2N6O4S2. Mole weight: 665.65. Catalog: APB01812. | |
Our database is helping our users find suppliers everyday.
